 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
LITT.V - Roadman Investments Corp. (Psychedelics) Roadman Investments is a Canadian venture capital and advisory firm listed on the Canadian Securities Exchange ( TSXV:LITT)( FWB:1QD). Roadman strives to actively drive innovation and accelerate growth within its portfolio holdings, with the objective of realizing alpha returns. Roadman is mandated with deploying investment capital and advisory services to both public and private companies. Roadman’s investment committee looks to identify companies with a strong potential for accretive revenue and profitability in the following sectors: INVESTMENT PHILOSOPHY Roadman Investments is a research-driven investment firm and each portfolio selection goes through methodical analysis. The company uses a broad spectrum of investment strategies across industries and capitalization ranges. A cornerstone of our philosophy lies in the consistent application of a rigorous investment approach that analyzes not only the financial and business prospects of the companies we invest in but also the the fundamental macro drivers of the industry. The vision and talent of the founders is the drive behind the company and one of our most important considerations. Roadman Investments only partners with entrepreneurs that are highly competent and committed. Our culture stresses teamwork and the free exchange of ideas among our executives and key industry experts to ensure calculated and data driven decisions. Roadman Investments strives for excellence in portfolio selection, strategic capital allocation and its ability to surpass our partner’s expectations. CURRENT FOCUS Roadman plans to achieve significant growth by investing in securities of companies engaged in health and wellness, nutrition, new forms of medicines, pharmaceutical products and others. In the near term Roadman aims to acquire assets in cultivation, distribution, consumer products and research and development in the medicinal mushroom sector. THE ROADMAN DIFFERENCE The firm’s most distinctive strength is its proprietary, independent research and it’s connections to leading experts in the medicinal mushroom industry. It is this comprehensive approach that is positioning Roadman as a future frontrunner in the fast growing alternative health industry. HEALTH & WELLNESS DISRUPTION The world is becoming more health conscious than ever before and wellness needs are growing daily. In pursuit of a more preventative approach to staying healthy, consumers are opting for more conscious nutritional and drug alternatives. Roadman believes that the future of the $4.2 trillion worldwide wellness market relies on appealing to the population that seeks pharmaceutical free alternatives and more natural cures. Roadman is committed to investing in breakthrough products, devices, treatments and health supplements that promote holistic health and wellness. | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |